Geode Capital Management, LLC Bio N Tech Se Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Geode Capital Management, LLC holds 92,410 shares of BNTX stock, worth $7.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,410

Previous 90,427 2.19%

Holding current value

$7.38 Million

Previous $9.54 Million 10.68%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $176,407 - $222,790	1,983 Added 2.19%	92,410 $8.52 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $214,729 - $266,315	2,362 Added 2.68%	90,427 $9.54 Million
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $122,632 - $155,724	1,245 Added 1.43%	88,065 $9.57 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $257,270 - $325,187	2,508 Added 2.97%	86,820 $9.37 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $120,118 - $150,596	980 Added 1.18%	84,312 $10.5 Million

Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $458,324 - $720,013	3,870 Added 4.87%	83,332 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $277,255 - $397,714	2,172 Added 2.81%	79,462 $10.7 Million
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $1.39 Million - $2.1 Million	11,250 Added 17.04%	77,290 $11.5 Million
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $19,947 - $36,632	158 Added 0.24%	66,040 $11.3 Million
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $1.51 Million - $2.52 Million	6,958 Added 11.81%	65,882 $17 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $383,029 - $831,847	1,860 Added 3.26%	58,924 $16.1 Million
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $147,769 - $314,902	1,304 Added 2.34%	57,064 $12.8 Million
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $654,548 - $912,382	7,635 Added 15.86%	55,760 $6.09 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $594,622 - $1.06 Million	8,178 Added 20.47%	48,125 $3.92 Million
Q3 2020 Nov 13, 2020	BUY	$57.81 - $104.17 $1.93 Million - $3.48 Million	33,361 Added 506.54%	39,947 $2.77 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $20,833 - $36,039	540 Added 8.93%	6,586 $439,000
Q1 2020 May 14, 2020	BUY	$28.55 - $92.0 $172,613 - $556,232	6,046 New	6,046 $353,000

Others Institutions Holding BNTX

# of Institutions

327

Shares Held

40.4M

Call Options Held

1.31M

Put Options Held

1.37M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Bio N Tech Se Transaction History